A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

Multiple Sclerosis Journal

Volumn 21, Issue 3, 2015, Pages 342-349

  Marrie, Ruth Ann ^a   Reider, Nadia ^a   Cohen, Jeffrey ^b   Trojano, Maria ^c   Sorensen, Per Soelberg ^d   Cutter, Gary ^e   Reingold, Stephen ^f   Stuve, Olaf ^g  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c University of Texas Southwestern   (United States)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Scientific and Clinical Review Associates LLC   (United States)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

comorbidity; epilepsy; incidence; Multiple sclerosis; prevalence; seizures; sleep

Indexed keywords

ASIA; COMORBIDITY; EUROPE; HUMAN; INCIDENCE; MULTIPLE SCLEROSIS; NARCOLEPSY; NORTH AMERICA; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PREVALENCE; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SELF REPORT; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SOUTH AMERICA; SYSTEMATIC REVIEW; COMPLICATION; EPILEPSY; SLEEP WAKE DISORDERS; CENTRAL SLEEP APNEA SYNDROME; FACTUAL DATABASE; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; STUDY DESIGN;

COMORBIDITY; EPILEPSY; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; PREVALENCE; SLEEP WAKE DISORDERS;

EID: 84924798298     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514564486     Document Type: Review

References (65)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002 ; 359: 1221-1231
2. Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon- treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry. 2013 ; 84: 1186-1191
3. Warren SA, Turpin KV, Pohar SL, et al. Comorbidity and health-related quality of life in people with multiple sclerosis. Int J MS Care. 2009 ; 11: 6-16
4. Finlayson M, Preissner K, Cho C. Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis. Int J MS Care. 2013 ; 15: 21-26
5. Nicoletti A, Sofia V, Biondi R, et al. Epilepsy and multiple sclerosis in Sicily: a population-based study. Epilepsia. 2003 ; 44: 1445-1448
6. Nicoletti A, Patti F, Fermo SL, et al. Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia. 2008 ; 28: 1163-1169
7. Krokki O, Bloigu R, Ansakorpi H, et al. Neurological comorbidity and survival in multiple sclerosis. Mult Scler Relat Disorders. 2013 ; 3: 72-77
8. Villani V, Prosperini L, Pozzilli C, et al. Quality of life of multiple sclerosis patients with comorbid migraine. Neurol Sci. 2011 ; 32: 149-151
9. Foley PL, Vesterinen HM, Laird BJ, et al. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain. 2013 ; 154: 632-642
10. Marrie R, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scle. Vol 21: 6
11. Neyeloff J, Fuchs S, Moreira L. Meta-analyses and forest plots using a Microsoft Excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012 ; 5: 52
12. Cox DR. The continuity correction. Biometrika. 1970 ; 57: 217-219
13. Allen AN, Seminog OO, Goldacre MJ. Association between multiple sclerosis and epilepsy: large population-based record-linkage studies. BMC Neurol. 2013 ; 13: 189
14. Brichetto G, Uccelli MM, Mancardi GL, et al. Symptomatic medication use in multiple sclerosis. Mult Scler. 2003 ; 9: 458-460
15. Catenoix H, Marignier R, Ritleng C, et al. Multiple sclerosis and epileptic seizures. Mult Scler. 2011 ; 17: 96-102
16. Cendrowski W, Majkowski J. Epilepsy in multiple sclerosis. J Neurol Sci. 1972 ; 17: 389-398
17. Cheng MY, Wai YY, Ro LS, et al. Seizures and multiple sclerosis in Chinese patients: a clinical and magnetic resonance imaging study. Epilepsy Res. 2012 ; 101: 166-173
18. Drake WE, Macrae D. Epilepsy in multiple sclerosis. Neurology. 1961 ; 11: 810-816
19. Durmus H, Kurtuncu M, Tuzun E, et al. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurol Belg. 2013 ; 113: 421-426
20. Engelsen BA, Gronning M. Epileptic seizures in patients with multiple sclerosis. Is the prognosis of epilepsy underestimated?. Seizure. 1997 ; 6: 377-382
21. Eriksson M, Ben-Menachem E, Andersen O. Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis. Mult Scler. 2002 ; 8: 495-499
22. Etemadifar M, Abtahi SH, Roomizadeh P. Epileptic seizures in multiple sclerosis: a population-based survey in Iran. Acta Neurol Belg. 2013 ; 113: 271-278
23. Etemadifar M, Abtahi SH, Tabrizi N. Epileptic seizures in early-onset multiple sclerosis. Arch Iran Med. 2012 ; 15: 381-383
24. Gambardella A, Valentino P, Labate A, et al. Temporal lobe epilepsy as a unique manifestation of multiple sclerosis. Can J Neurol Sci. 2003 ; 30: 228-232
25. Ghezzi A, Montanini R, Basso PF, et al. Epilepsy in multiple sclerosis. Eur Neurol. 1990 ; 30: 218-223
26. Horton M, Rudick RA, Hara-Cleaver C, et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 83-90
27. Kang J-H, Chen Y-H, Lin H-C. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol. 2010 ; 17: 1215-1219
28. Kinnunen E, Wikstrom J. Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia. 1986 ; 27: 729-733
29. Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology. 2013 ; 40: 85-92
30. Martinez-Lapiscina EH, Ayuso T, Lacruz F, et al. Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis. Acta Neurol Scand. 2013 ; 128: 24-31
31. Moreau T, Sochurkova D, Lemesle M, et al. Epilepsy in patients with multiple sclerosis: radiological-clinical correlations. Epilepsia. 1998 ; 39: 893-896
32. Nuyen J, Schellevisa FG, Satarianob WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol. 2006 ; 59: 1274-1284
33. Nyquist PA, Cascino GD, McClelland RL, et al. Incidence of seizures in patients with multiple sclerosis: a population-based study. Mayo Clinic Proc. 2002 ; 77: 910-912
34. Nyquist PA, Cascino GD, Rodriguez M. Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990-1998. Mayo Clin Proc. 2001 ; 76: 983-986
35. Olafsson E, Benedikz J, Hauser WA. Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland. Epilepsia. 1999 ; 40: 745-747
36. Shaygannejad V, Ashtari F, Zare M, et al. Seizure characteristics in multiple sclerosis patients. J Res Med Sci. 2013 ; 18: S74 - S77
37. Shiraishi K, Higuchi Y, Ozawa K, et al. Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan. Brain Dev. 2005 ; 27: 224-227
38. Sokic DV, Stojsavljevic N, Drulovic J, et al. Seizures in multiple sclerosis. Epilepsia. 2001 ; 42: 72-79
39. Striano P, Orefice G, Brescia Morra V, et al. Epileptic seizures in multiple sclerosis: clinical and EEG correlations. Neurol Sci. 2003 ; 24: 322-328
40. Trouillas P, Courjon J. Epilepsy with multiple sclerosis. Epilepsia. 1972 ; 13: 325-333
41. Uribe-San-Martin R, Ciampi-Diaz E, Suarez-Hernandez F, et al. Prevalence of epilepsy in a cohort of patients with multiple sclerosis. Seizure. 2014 ; 23: 81-83
42. Viveiros CD, Alvarenga RM. Prevalence of epilepsy in a case series of multiple sclerosis patients. Arq Neuropsiquiatr. 2010 ; 68: 731-736
43. Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology. 2012 ; 79: 929-936
44. Deriu M, Cossu G, Molari A, et al. Restless legs syndrome in multiple sclerosis: a case-control study. Mov Disorders. 2009 ; 24: 697-701
45. Dias RA, Hardin KA, Rose H, et al. Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study. Sleep Breath. 2012 ; 16: 1255-65
46. Ferini-Strambi L, Filippi M, Martinelli V, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci. 1994 ; 125: 194-197
47. Fragoso YD, Finkelsztejn A, Gomes S, et al. Restless legs syndrome and multiple sclerosis: a Brazilian multicenter study and meta-analysis of the literature. Arq Neuropsiquiatr. 2011 ; 69: 180-183
48. Gomez-Choco M, Iranzo A, Blanco Y, et al. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007 ; 13: 805-808
49. Kaminska M, Kimoff RJ, Benedetti A, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. 2012 ; 18: 1159-1169
50. Li Y, Munger KL, Batool-Anwar S, et al. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology. 2012 ; 78: 1500-1506
51. Manconi M, Fabbrini M, Bonanni E, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol. 2007 ; 14: 534-539
52. Manconi M, Ferini-Strambi L, Filippi M, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep. 2008 ; 31: 944-952
53. Manconi M, Rocca MA, Ferini-Strambi L, et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler. 2008 ; 14: 86-93
54. Miri S, Rohani M, Sahraian MA, et al. Restless legs syndrome in Iranian patients with multiple sclerosis. Neurol Sci. 2013 ; 34: 1105-1108
55. Moreira NC, Damasceno RS, Medeiros CA, et al. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res. 2008 ; 41: 932-937
56. Poirier G, Montplaisir J, Dumont M, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987 ; 37: 693-695
57. Shaygannejad V, Ardestani PE, Ghasemi M, et al. Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study. Int J Prev Med. 2013 ; 4: S189 - S193
58. Tachibana N, Howard RS, Hirsch NP, et al. Sleep problems in multiple sclerosis. Eur Neurol. 1994 ; 34: 320-323
59. Vavrova J, Kemlink D, Sonka K, et al. Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study. Sleep Med. 2012 ; 13: 848-851
60. Auger C, Montplaisir J, Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology. 2005 ; 65: 1652-1653
61. Lamberg L. Sleep disorders, often unrecognized, complicate many physical illnesses. JAMA. 2000 ; 284: 2173-2175
62. Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis. 2009 ; 51: 285-293
63. Hiestand DM, Britz P, Goldman M, et al. Prevalence of symptoms and risk of sleep apnea in the US population: Results from the National Sleep Foundation Sleep in America 2005 Poll. Chest. 2006 ; 130: 780-786
64. Bamer AM, Johnson KL, Amtmann D, et al. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008 ; 14: 1127-1130
65. Lobentanz IS, Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004 ; 110: 6-13